BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23692168)

  • 1. Bedside to gene and back in idiopathic pulmonary fibrosis.
    Cookson WO; Moffatt MF
    N Engl J Med; 2013 Jun; 368(23):2228-30. PubMed ID: 23692168
    [No Abstract]   [Full Text] [Related]  

  • 2. MUC5B promoter polymorphism and pulmonary fibrosis.
    Zhang GY; Liao T; Gao WY
    N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751917
    [No Abstract]   [Full Text] [Related]  

  • 3. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.
    Conti C; Montero-Fernandez A; Borg E; Osadolor T; Viola P; De Lauretis A; Stock CJ; Bonifazi M; Bonini M; Caramori G; Lindahl G; Blasi FB; Nicholson AG; Wells AU; Sestini P; Renzoni E
    Am J Respir Crit Care Med; 2016 Feb; 193(4):462-4. PubMed ID: 26871672
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
    Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
    PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background.
    Borie R; Kannengiesser C; Crestani B
    Curr Opin Pulm Med; 2012 Sep; 18(5):455-61. PubMed ID: 22781209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC5B promoter polymorphism and interstitial lung abnormalities.
    Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
    N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MUC5B promoter polymorphism with interstitial lung changes after COVID-19: A preliminary observation.
    Dhooria S; Bal A; Sharma R; Prabhakar N; Arora S; Sehgal IS; Kashyap D; Garg M; Bhalla A; Aggarwal AN; Agarwal R
    Indian J Med Res; 2024 Jan; 159(1):109-113. PubMed ID: 38344913
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards clinical significance of the
    Sparks JA
    Ann Rheum Dis; 2021 Dec; 80(12):1503-1504. PubMed ID: 34344705
    [No Abstract]   [Full Text] [Related]  

  • 11. The genetic and environmental causes of pulmonary fibrosis.
    Macneal K; Schwartz DA
    Proc Am Thorac Soc; 2012 Jul; 9(3):120-5. PubMed ID: 22802285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.
    Ash SY; Harmouche R; Putman RK; Ross JC; Diaz AA; Hunninghake GM; Onieva Onieva J; Martinez FJ; Choi AM; Lynch DA; Hatabu H; Rosas IO; San Jose Estepar R; Washko GR;
    Chest; 2017 Oct; 152(4):780-791. PubMed ID: 28506611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the
    Matson SM; Deane KD; Peljto AL; Bang TJ; Sachs PB; Walts AD; Collora C; Ye S; Demoruelle MK; Humphries SM; Schwartz DA; Lee JS
    Am J Respir Crit Care Med; 2022 Feb; 205(4):473-476. PubMed ID: 34874815
    [No Abstract]   [Full Text] [Related]  

  • 14. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
    Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
    Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of
    Namba N; Kawasaki A; Sada KE; Hirano F; Kobayashi S; Yamada H; Furukawa H; Shimada K; Hashimoto A; Matsui T; Nagasaka K; Sugihara T; Suzuki A; Yamagata K; Sumida T; Tohma S; Homma S; Ozaki S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N;
    Ann Rheum Dis; 2019 Aug; 78(8):1144-1146. PubMed ID: 30765393
    [No Abstract]   [Full Text] [Related]  

  • 16. Interstitial Lung Abnormality: Recognition and Perspectives.
    Hatabu H; Hunninghake GM; Lynch DA
    Radiology; 2019 Apr; 291(1):1-3. PubMed ID: 30561274
    [No Abstract]   [Full Text] [Related]  

  • 17. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic basis of idiopathic pulmonary fibrosis.
    Kropski JA; Blackwell TS; Loyd JE
    Eur Respir J; 2015 Jun; 45(6):1717-27. PubMed ID: 25837031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.